ECSP067108A - Inhibidor de 11-beta-hidroxi esteroide deshidrogenasa tipo 1 - Google Patents

Inhibidor de 11-beta-hidroxi esteroide deshidrogenasa tipo 1

Info

Publication number
ECSP067108A
ECSP067108A EC2006007108A ECSP067108A ECSP067108A EC SP067108 A ECSP067108 A EC SP067108A EC 2006007108 A EC2006007108 A EC 2006007108A EC SP067108 A ECSP067108 A EC SP067108A EC SP067108 A ECSP067108 A EC SP067108A
Authority
EC
Ecuador
Prior art keywords
hydroxi
beta
inhibitor
dehydrogenase type
steroid dehydrogenase
Prior art date
Application number
EC2006007108A
Other languages
English (en)
Inventor
Martin Henriksson
Evert Homan
Lars Johansson
Jerk Vallgarda
Meredith Williams
Eric Bercot
Christopher H Fotsch
Aiwen Li
Guolin Cai
Randall W Hungate
Chester Chenguang Yuan
Christopher Tegley
Jean David St
Inane Han
Qi Huang
Qingyian Liu
Michael D Bartberger
George A Moniz
Matthew J Frizzle
Original Assignee
Amgen Inc
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0401324A external-priority patent/SE0401324D0/xx
Priority claimed from SE0402509A external-priority patent/SE0402509D0/xx
Application filed by Amgen Inc, Biovitrum Ab filed Critical Amgen Inc
Publication of ECSP067108A publication Critical patent/ECSP067108A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a compuestos con la formula (I), (II), (III) o (IV): (I) (II), (III), o (IV),en los cuales R1, R2, R3, R4, R5, R6, R7, X y Z son como se define aquí,y además a composiciones farmacéuticas que comprenden los compuestos, como también métodos de uso de los compuestos para el tratamiento de trastornos asociados con la enzima deshidrogenasa 11-ß-hidroxiesteroide tipo 1 y para la preparación de un medicamento que actúa sobre la enzima deshidrogenasa 11-ß-hidroxiesteroide tipo 1 humana.
EC2006007108A 2004-05-24 2006-12-21 Inhibidor de 11-beta-hidroxi esteroide deshidrogenasa tipo 1 ECSP067108A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0401324A SE0401324D0 (sv) 2004-05-24 2004-05-24 New compounds
SE0402509A SE0402509D0 (sv) 2004-10-15 2004-10-15 New compounds
US65077705P 2005-01-31 2005-01-31

Publications (1)

Publication Number Publication Date
ECSP067108A true ECSP067108A (es) 2007-05-30

Family

ID=41717469

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006007108A ECSP067108A (es) 2004-05-24 2006-12-21 Inhibidor de 11-beta-hidroxi esteroide deshidrogenasa tipo 1

Country Status (10)

Country Link
KR (1) KR101296408B1 (es)
CR (2) CR8771A (es)
EC (1) ECSP067108A (es)
HK (1) HK1096095A1 (es)
HR (1) HRP20060456A2 (es)
IL (1) IL179167A (es)
MA (1) MA28662B1 (es)
MX (1) MXPA06013657A (es)
NO (1) NO20065781L (es)
NZ (1) NZ552284A (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228111B1 (en) 1998-07-08 2012-11-28 Sanofi Aventis Deutschland Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Also Published As

Publication number Publication date
NZ552284A (en) 2010-01-29
HRP20060456A2 (en) 2007-03-31
MXPA06013657A (es) 2007-11-07
MA28662B1 (fr) 2007-06-01
IL179167A0 (en) 2007-03-08
CR8771A (es) 2007-07-24
HK1096095A1 (en) 2007-05-25
CR20120420A (es) 2012-09-14
NO20065781L (no) 2007-02-08
KR20070058382A (ko) 2007-06-08
KR101296408B1 (ko) 2013-08-13
IL179167A (en) 2012-01-31

Similar Documents

Publication Publication Date Title
CR9987A (es) Compuestos de lactama y métodos de uso de los mismos
BRPI0510394A (pt) inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1
ECSP077309A (es) Compuestos amido y sus usos como farmaceuticos
BRPI0411528A (pt) uso de isomalte como prebiótico
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
ECSP109903A (es) Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares
DK1819227T3 (da) Farmaceutisk formulering af decitabin
CR8796A (es) Compuestos amido y su uso como farmacos
BRPI0815708A8 (pt) composto derivado de benzilbenzeno como inibidor de sglt, composição farmacêutica, e, uso de um composto
GT200500325A (es) Pirazolo-pirimidinas 1,4-sustituidas como inhibidores de quinasa
ECSP077275A (es) Novedosos derivados de heteroarilsulfamida benzofusionados utiles como agentes anticonvulsivos
SV1999000118A (es) Nuevos derivados de pirazol substituidos ref. lea 33188-sv
CL2008001839A1 (es) Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
AR047529A1 (es) Compuestos de quinolina sustituidos
EA200601648A1 (ru) Глюкозамин и общие пролекарства глюкозамин/противовоспалительный агент, композиции и способы
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
DOP2005000064A (es) Nuevos compuestos
PA8632701A1 (es) Compuestos terapeuticos
UY29963A1 (es) Compuestos terapéuticos: piridinas y pirazinas como andamios
UY30220A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
ECSP003610A (es) Pirimidina-2,4,6 trionas inhibidores de metaloproteinas
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
UY28144A1 (es) Agentes terapéuticos
SE0401342D0 (sv) Therapeutic compounds